litlas
ログインアカウント作成

Nigel H. Greig

1984–2026 年に発表

180
論文数
24,359
被引用数
87
h 指数
171
i10 指数

被引用数

Nigel H. Greig の年別被引用数1986 年: 被引用 2 件1987 年: 被引用 3 件1988 年: 被引用 2 件1989 年: 被引用 6 件1990 年: 被引用 7 件1991 年: 被引用 6 件1992 年: 被引用 10 件1993 年: 被引用 5 件1994 年: 被引用 6 件1995 年: 被引用 4 件1996 年: 被引用 9 件1997 年: 被引用 9 件1998 年: 被引用 12 件1999 年: 被引用 19 件2000 年: 被引用 22 件2001 年: 被引用 44 件2002 年: 被引用 91 件2003 年: 被引用 130 件2004 年: 被引用 130 件2005 年: 被引用 135 件2006 年: 被引用 173 件2007 年: 被引用 130 件2008 年: 被引用 158 件2009 年: 被引用 164 件2010 年: 被引用 204 件2011 年: 被引用 259 件2012 年: 被引用 322 件2013 年: 被引用 259 件2014 年: 被引用 262 件2015 年: 被引用 221 件2016 年: 被引用 219 件2017 年: 被引用 266 件2018 年: 被引用 300 件2019 年: 被引用 984 件2020 年: 被引用 1,149 件2021 年: 被引用 1,156 件2022 年: 被引用 1,127 件2023 年: 被引用 820 件2024 年: 被引用 1,304 件2025 年: 被引用 864 件2026 年: 被引用 38 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,507 件、この内訳の 20.5%中国: 引用元論文 1,800 件、この内訳の 14.7%インド: 引用元論文 622 件、この内訳の 5.1%イギリス: 引用元論文 610 件、この内訳の 5%イタリア: 引用元論文 540 件、この内訳の 4.4%ドイツ: 引用元論文 403 件、この内訳の 3.3%カナダ: 引用元論文 389 件、この内訳の 3.2%オーストラリア: 引用元論文 302 件、この内訳の 2.4%韓国: 引用元論文 299 件、この内訳の 2.4%スペイン: 引用元論文 290 件、この内訳の 2.4%フランス: 引用元論文 255 件、この内訳の 2.1%サウジアラビア: 引用元論文 215 件、この内訳の 1.7%
0%20.5%その他 32.8%

機関

分野

  • Medicine59.6%
  • Biochemistry, Genetics and Molecular Biology17.2%
  • Neuroscience13.2%
  • Computer Science2.5%
  • Nursing1.4%
  • Agricultural and Biological Sciences1.3%
  • その他4.8%

トピック

  • Alzheimer's disease research and treatments8.2%
  • Cholinesterase and Neurodegenerative Diseases6.3%
  • Computational Drug Discovery Methods4.8%
  • Neuroinflammation and Neurodegeneration Mechanisms4%
  • Diabetes Treatment and Management3%
  • Parkinson's Disease Mechanisms and Treatments2.9%
  • その他70.8%

共著者

全論文

検索で開く
  1. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

    著者: Evandro Fei Fang, Yujun Hou, Konstantinos Palikaras, Bryan A. Adriaanse, Jesse S. Kerr, Beimeng Yang, Sofie Lautrup, Md Mahdi Hasan‐Olive, Domenica Caponio, Xiuli Dan, Paula Rocktäschel, Deborah L. Croteau, Mansour Akbari, Nigel H. Greig, Tormod Fladby, Hilde Nilsen, M. Zameel Cader, Mark P. Mattson, Nektarios Tavernarakis, Vilhelm A. Bohr - Nature Neuroscience 2019 被引用: 1,696

  2. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    著者: Dilan Athauda, Kate Maclagan, Simon S. Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson, Yazhou Li, Icíar Avilés-Olmos, Thomas T. Warner, Patricia Limousin, Andrew J. Lees, Nigel H. Greig, Susan Tebbs, Thomas Foltynie - The Lancet 2017 被引用: 851

  3. Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms

    著者: Jesse S. Kerr, Bryan A. Adriaanse, Nigel H. Greig, Mark P. Mattson, M. Zameel Cader, Vilhelm A. Bohr, Evandro Fei Fang - Trends in Neurosciences 2017 被引用: 872

  4. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

    著者: Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, Nigel H. Greig - Pharmacological Research 2022 被引用: 254

  5. Drug discovery and development: Role of basic biological research

    著者: Richard C. Mohs, Nigel H. Greig - Alzheimer s & Dementia Translational Research & Clinical Interventions 2017 被引用: 679

  6. Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis

    著者: Daniela Lecca, Yoo Jin Jung, Michael T. Scerba, Inho Hwang, Yu Kyung Kim, Sun Kim, Sydney Modrow, David Tweedie, Shih‐Chang Hsueh, Dong Liu, Weiming Luo, Elliot J. Glotfelty, Yazhou Li, Jia‐Yi Wang, Yu Luo, Barry J. Hoffer, Dong Seok Kim, Ross A. McDevitt, Nigel H. Greig - Alzheimer s & Dementia 2022 被引用: 211

  7. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function

    著者: Hyo Youl Moon, Andreas Becke, David Berron, Benjamin Becker, Nirnath Sah, Galit Benoni, Emma Janke, Susan T. Lubejko, Nigel H. Greig, Julie A. Mattison, Emrah Düzel, Henriette van Praag - Cell Metabolism 2016 被引用: 617

  8. Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus

    著者: Gohar Mushtaq, Nigel H. Greig, Jalaluddin A. Khan, Mohammad Amjad Kamal - CNS & Neurological Disorders - Drug Targets 2014 被引用: 317

  9. A Pilot Study of Exenatide Actions in Alzheimer’s Disease

    著者: Roger J. Mullins, Maja Mustapić, Chee W. Chia, Olga D. Carlson, Seema Gulyani, Joyce Tran, Yazhou Li, Mark P. Mattson, Susan M. Resnick, Josephine M. Egan, Nigel H. Greig, Dimitrios Kapogiannis - Current Alzheimer Research 2019 被引用: 149

  10. Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

    著者: Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, Yazhou Li, David Tweedie, Maja Mustapić, Sahil Chawla, Kashfia Chowdhury, Simon S. Skene, Nigel H. Greig, Dimitrios Kapogiannis, Thomas Foltynie - JAMA Neurology 2019 被引用: 256

  11. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

    著者: James Mitchell, Hannah Lyons, Jessica Walker, Andreas Yiangou, Olivia Grech, Zerin Alimajstorovic, Nigel H. Greig, Yazhou Li, Georgios Tsermoulas, Kristian Brock, Susan P. Mollan, Alexandra J. Sinclair - Brain 2023 被引用: 145

  12. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

    著者: Nigel H. Greig, Tadanobu Utsuki, Donald K. Ingram, Yue Wang, Giancarlo Pepeu, Carla Scali, Qian-sheng Yu, Jacek Mamczarz, Harold W. Holloway, Tony Giordano, De‐Mao Chen, Katsutoshi Furukawa, Kumar Sambamurti, Arnold Brossi, Debomoy K. Lahiri - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 被引用: 723

  13. N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

    著者: David Olivares, Varun K. Deshpande, Ying Shi, Debomoy K. Lahiri, Nigel H. Greig, Jack T. Rogers, Xudong Huang - Current Alzheimer Research 2012 被引用: 393

  14. Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

    著者: Isidro Salcedo, David Tweedie, Yazhou Li, Nigel H. Greig - British Journal of Pharmacology 2012 被引用: 259

  15. Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

    著者: Nirosen Vijiaratnam, Christine Girges, Grace Auld, Rachel McComish, Alexa King, Simon S. Skene, Steve Hibbert, Alan Wong, Sabina Melander, Rachel Gibson, Helen Matthews, John Dickson, Camille Carroll, Abigail Patrick, Jemma Inches, Monty Silverdale, Bethan Blackledge, Jessica Whiston, Michele Hu, Jessica Welch, Gordon W. Duncan, Katie Power, Sarah Gallen, Jacqueline Kerr, К. Ray Chaudhuri, Lucia Batzu, Silvia Rota, Edwin Jabbari, Huw R. Morris, Patricia Limousin, Nigel H. Greig, Yazhou Li, Vincenzo Libri, Sonia Gandhi, Dilan Athauda, Kashfia Chowdhury, Tom Foltynie - The Lancet 2025 被引用: 121

  16. Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4

    著者: TracyAnn Perry, Norman J. Haughey, Mark P. Mattson, Josephine M. Egan, Nigel H. Greig - Journal of Pharmacology and Experimental Therapeutics 2002 被引用: 374

  17. An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript

    著者: Jack T. Rogers, Jeffrey Randall, Catherine M. Cahill, Paul S. Eder, Xudong Huang, Hiromi Gunshin, Lorene M. Leiter, Jay A. McPhee, Satinder S. Sarang, Tada Utsuki, Nigel H. Greig, Debomoy K. Lahiri, Rudolph E. Tanzi, Ashley I. Bush, Tony Giordano, S. R. Gullans - Journal of Biological Chemistry 2002 被引用: 546

  18. Butyrylcholinesterase: An Important New Target in Alzheimer’s Disease Therapy

    著者: Nigel H. Greig, Debomoy K. Lahiri, Kumar Sambamurti - International Psychogeriatrics 2002 被引用: 456

  19. GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

    著者: Yazhou Li, Kara B. Duffy, Mary Ann Ottinger, Balmiki Ray, Jason A. Bailey, Harold W. Holloway, David Tweedie, TracyAnn Perry, Mark P. Mattson, Dimitrios Kapogiannis, Kumar Sambamurti, Debomoy K. Lahiri, Nigel H. Greig - Journal of Alzheimer s Disease 2010 被引用: 324

  20. Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus

    著者: Ghulam Md Ashraf, Nigel H. Greig, Taqi Ahmed Khan, Iftekhar Hassan, Shams Tabrez, Shazi Shakil, Ishfaq A. Sheikh, Syed Kashif Zaidi, Mohammad Akram, Nasimudeen R. Jabir, Chelaprom Firoz, Aabgeena Naeem, Ibrahim M. Alhazza, Ghazi Damanhouri, Mohammad Amjad Kamal - CNS & Neurological Disorders - Drug Targets 2014 被引用: 238

  21. Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A MultimodalTherapeutic Target in Traumatic Brain Injury

    著者: Aziz Unnisa, Nigel H. Greig, Mohammad Amjad Kamal - Current Neuropharmacology 2022 被引用: 125

  22. The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia

    著者: Elliot J. Glotfelty, Luis B. Tovar‐y‐Romo, Shih‐Chang Hsueh, David Tweedie, Yazhou Li, Brandon K. Harvey, Barry J. Hoffer, Tobias E. Karlsson, Lars Olson, Nigel H. Greig - Cells 2023 被引用: 53

  23. A Novel Neurotrophic Property of Glucagon-Like Peptide 1: A Promoter of Nerve Growth Factor-Mediated Differentiation in PC12 Cells

    著者: TracyAnn Perry, Debomoy K. Lahiri, De‐Mao Chen, Jie Zhou, Karen T. Y. Shaw, Josephine M. Egan, Nigel H. Greig - Journal of Pharmacology and Experimental Therapeutics 2002 被引用: 298

  24. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

    著者: Yoo Jin Jung, David Tweedie, Michael T. Scerba, Nigel H. Greig - Frontiers in Cell and Developmental Biology 2019 被引用: 148